242 related articles for article (PubMed ID: 18839430)
1. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.
Abbas S; Chang-Claude J; Linseisen J
Int J Cancer; 2009 Jan; 124(1):250-5. PubMed ID: 18839430
[TBL] [Abstract][Full Text] [Related]
2. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532
[TBL] [Abstract][Full Text] [Related]
3. Dietary vitamin D and calcium intake and premenopausal breast cancer risk in a German case-control study.
Abbas S; Linseisen J; Chang-Claude J
Nutr Cancer; 2007; 59(1):54-61. PubMed ID: 17927502
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case-Control Study.
Jamshidinaeini Y; Akbari ME; Abdollahi M; Ajami M; Davoodi SH
J Am Coll Nutr; 2016; 35(7):639-646. PubMed ID: 27331363
[TBL] [Abstract][Full Text] [Related]
6. Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India.
Sofi NY; Jain M; Kapil U; Seenu V; Kamal VK; Pandey RM
J Steroid Biochem Mol Biol; 2018 Jan; 175():55-59. PubMed ID: 27687737
[TBL] [Abstract][Full Text] [Related]
7. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
Bilinski K; Boyages J
Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
[TBL] [Abstract][Full Text] [Related]
8. Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II.
Eliassen AH; Spiegelman D; Hollis BW; Horst RL; Willett WC; Hankinson SE
Breast Cancer Res; 2011 May; 13(3):R50. PubMed ID: 21569367
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D and breast cancer risk by pathological subtype (MCC-Spain).
Lope V; Castelló A; Mena-Bravo A; Amiano P; Aragonés N; Fernández-Villa T; Guevara M; Dierssen-Sotos T; Fernandez-Tardón G; Castaño-Vinyals G; Marcos-Gragera R; Moreno V; Salas-Trejo D; Diaz-Santos M; Oribe M; Romieu I; Kogevinas M; Priego-Capote F; Pérez-Gómez B; Pollán M
J Steroid Biochem Mol Biol; 2018 Sep; 182():4-13. PubMed ID: 29679754
[TBL] [Abstract][Full Text] [Related]
11. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548
[TBL] [Abstract][Full Text] [Related]
12. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
[TBL] [Abstract][Full Text] [Related]
13. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
[TBL] [Abstract][Full Text] [Related]
14. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.
Bertrand KA; Rosner B; Eliassen AH; Hankinson SE; Rexrode KM; Willett W; Tamimi RM
Breast Cancer Res Treat; 2015 Jan; 149(2):479-87. PubMed ID: 25543181
[TBL] [Abstract][Full Text] [Related]
15. Serum 25-hydroxyvitamin D and mammographic density in premenopausal Spanish women.
Lope V; Toribio MJ; Pérez-Gómez B; Castelló A; Mena-Bravo A; Sierra MÁ; Lucas P; Herrán-Vidaurrázaga MDC; González-Vizcayno C; Pino MN; Cruz-Campos I; Roca-Navarro MJ; Aragonés N; Romieu I; Martínez-Cortés M; Luque de Castro MD; Pollán M
J Steroid Biochem Mol Biol; 2019 May; 189():101-107. PubMed ID: 30836177
[TBL] [Abstract][Full Text] [Related]
16. Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II.
Wang J; Eliassen AH; Spiegelman D; Willett WC; Hankinson SE
Cancer Causes Control; 2014 Jul; 25(7):819-27. PubMed ID: 24748579
[TBL] [Abstract][Full Text] [Related]
17. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.
McCullough ML; Stevens VL; Patel R; Jacobs EJ; Bain EB; Horst RL; Gapstur SM; Thun MJ; Calle EE
Breast Cancer Res; 2009; 11(4):R64. PubMed ID: 19715600
[TBL] [Abstract][Full Text] [Related]
18. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
Piller R; Chang-Claude J; Linseisen J
Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study.
Yao S; Sucheston LE; Millen AE; Johnson CS; Trump DL; Nesline MK; Davis W; Hong CC; McCann SE; Hwang H; Kulkarni S; Edge SB; O'Connor TL; Ambrosone CB
PLoS One; 2011 Feb; 6(2):e17251. PubMed ID: 21386992
[TBL] [Abstract][Full Text] [Related]
20. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]